158 related articles for article (PubMed ID: 1399206)
1. Recessive dystrophic epidermolysis bullosa treated with phenytoin.
Abahussein AA; al-Zayir AA; Mostafa WZ; Okoro AN
Int J Dermatol; 1992 Oct; 31(10):730-2. PubMed ID: 1399206
[TBL] [Abstract][Full Text] [Related]
2. [Phenytoin therapy in recessive dystrophic epidermolyses (epidermolysis bullosa dystrophica type Hallopeau-Siemens and epidermolysis bullosa dystrophica inversa)].
Wirth H; Nesch A; Ostapowicz B; Anton-Lamprecht I
Z Hautkr; 1983 Apr; 58(8):555-74. PubMed ID: 6858283
[TBL] [Abstract][Full Text] [Related]
3. Lack of efficacy of phenytoin in recessive dystrophic epidermolysis bullosa. Epidermolysis Bullosa Study Group.
Caldwell-Brown D; Stern RS; Lin AN; Carter DM
N Engl J Med; 1992 Jul; 327(3):163-7. PubMed ID: 1608407
[TBL] [Abstract][Full Text] [Related]
4. Phenytoin therapy of recessive dystrophic epidermolysis bullosa. Clinical trial and proposed mechanism of action on collagenase.
Bauer EA; Cooper TW; Tucker DR; Esterly NB
N Engl J Med; 1980 Oct; 303(14):776-81. PubMed ID: 6251365
[TBL] [Abstract][Full Text] [Related]
5. Darbepoetin alfa and ferric gluconate ameliorate the anemia associated with recessive dystrophic epidermolysis bullosa.
Kuo DJ; Bruckner AL; Jeng MR
Pediatr Dermatol; 2006; 23(6):580-5. PubMed ID: 17156003
[TBL] [Abstract][Full Text] [Related]
6. Epidermolysis bullosa in the eastern province of Saudi Arabia.
Abahussein AA; al-Zayir AA; Mostafa WZ; Okoro AN
Int J Dermatol; 1993 Aug; 32(8):579-81. PubMed ID: 8407073
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of phenytoin in recessive dystrophic epidermolysis. A comparison of short- and long-term treatment.
Cooper TW; Bauer EA
Arch Dermatol; 1984 Apr; 120(4):490-5. PubMed ID: 6703753
[TBL] [Abstract][Full Text] [Related]
8. Losartan as disease modulating therapy for recessive dystrophic epidermolysis bullosa.
Inamadar AC
Dermatol Ther; 2020 Nov; 33(6):e14279. PubMed ID: 32888385
[TBL] [Abstract][Full Text] [Related]
9. Dystrophic epidermolysis bullosa inversa: a case report.
Altomare GF; Polenghi M; Pigatto PD; Nazzaro V; Piattoni F
Dermatologica; 1990; 181(2):145-8. PubMed ID: 2173667
[TBL] [Abstract][Full Text] [Related]
10. First report of COL7A1 mutations in two patients with recessive dystrophic epidermolysis bullosa from Peru.
Saeidian AH; Youssefian L; Rosales-Solis GM; Vahidnezhad H; Atanasova VS; Uitto J; South AP; Salas-Alanis JC
Clin Exp Dermatol; 2018 Aug; 43(6):719-722. PubMed ID: 29427316
[No Abstract] [Full Text] [Related]
11. HLA and epidermolysis bullosa. Association between the HLA complex and recessive dystrophic epidermolysis bullosa.
Vaidya S; Tyring SK; Johnson LB; Fine JD
Arch Dermatol; 1991 Oct; 127(10):1524-7. PubMed ID: 1929459
[TBL] [Abstract][Full Text] [Related]
12. Topical sucralfate cream treatment for aplasia cutis congenita with dystrophic epidermolysis bullosa: a case study.
Yaşar Ş; Yaşar B; Cebeci F; Bayoğlu D; Nuhoğlu Ç
J Wound Care; 2018 Nov; 27(11):768-771. PubMed ID: 30398936
[TBL] [Abstract][Full Text] [Related]
13. [Squamous cell cancers in Hallopeau-Siemens recessive dystrophic epidermolysis bullosa].
Otte HG; Stieler W; Anton-Lamprecht I
Hautarzt; 1990 Sep; 41(9):494-8. PubMed ID: 2249946
[TBL] [Abstract][Full Text] [Related]
14. Skin expression of metalloproteinases and tissue inhibitor of metalloproteinases in sibling patients with recessive dystrophic epidermolysis and intrafamilial phenotypic variation.
Bodemer C; Tchen SI; Ghomrasseni S; Séguier S; Gaultier F; Fraitag S; de Prost Y; Godeau G
J Invest Dermatol; 2003 Aug; 121(2):273-9. PubMed ID: 12880418
[TBL] [Abstract][Full Text] [Related]
15. Moderation of phenotypic severity in dystrophic and junctional forms of epidermolysis bullosa through in-frame skipping of exons containing non-sense or frameshift mutations.
McGrath JA; Ashton GH; Mellerio JE; Salas-Alanis JC; Swensson O; McMillan JR; Eady RA
J Invest Dermatol; 1999 Sep; 113(3):314-21. PubMed ID: 10469327
[TBL] [Abstract][Full Text] [Related]
16. Gene expression of collagenase and stromelysin in skin fibroblasts derived from dystrophic epidermolysis bullosa.
Sugawara T; Nomura K; Hashimoto I
J Dermatol Sci; 1993 Oct; 6(2):172-80. PubMed ID: 8274463
[TBL] [Abstract][Full Text] [Related]
17. Junctional epidermolysis bullosa. Treatment with phenytoin.
Guill MF; Wray BB; Rogers RB; Yancey KB; Allen BS
Am J Dis Child; 1983 Oct; 137(10):992-4. PubMed ID: 6613946
[TBL] [Abstract][Full Text] [Related]
18. Persistent elevation of serum interleukin-6 and serum amyloid A levels in patients with recessive dystrophic epidermolysis bullosa.
Morizane S; Mizuno K; Takiguchi T; Ogita S; Nishida Y; Kawakami Y; Iwatsuki K
Eur J Dermatol; 2017 Feb; 27(1):80-81. PubMed ID: 27777188
[No Abstract] [Full Text] [Related]
19. Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients.
Woodley DT; Cogan J; Hou Y; Lyu C; Marinkovich MP; Keene D; Chen M
J Clin Invest; 2017 Aug; 127(8):3028-3038. PubMed ID: 28691931
[TBL] [Abstract][Full Text] [Related]
20. High-dose tocopherol acetate therapy in epidermolysis bullosa siblings of the Cockayne-Touraine type.
Shirakata Y; Shiraishi S; Sayama K; Shinmori H; Miki Y
J Dermatol; 1993 Nov; 20(11):723-5. PubMed ID: 8300945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
